HKSE · 2563.HK
Beijing Biostar Pharms Co Ltd
HK$3.40-HK$0.15 (-4.23%)
Beijing Biostar Pharms Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.24% below the high.
Loading market information…
HKSE · 1652.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:49 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Fusen Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 31.94% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fusen Pharmaceutical Company Limited’s forward annual dividend is HK$0.01 per share, paid semi-annual. The forward yield is 1.39% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fusen Pharmaceutical Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Fusen Pharmaceutical Company Limited operates as an investment holding enterprise, primarily engaged in the manufacturing and distribution of a diverse range of pharmaceutical products across the People's Republic of China. Its extensive product portfolio includes specific cold remedies based on Shuanghuanglian, offered as both oral solutions and injections, alongside medications like flunarizine hydrochloride capsules and compound ferrous sulfate granules. The company further provides Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. Beyond these, Fusen actively researches, develops, produces, and markets a variety of proprietary Chinese medicines and modern Western pharmaceuticals, targeting conditions such as colds, fevers, cardiovascular ailments, and anemia. Additionally, the firm offers business management and advisory services. Fusen Pharmaceutical Company Limited was established in 2003 and is headquartered in Nanyang, China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$3.40-HK$0.15 (-4.23%)
Beijing Biostar Pharms Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.24% below the high.
HK$2.35-HK$0.14 (-5.43%)
Pak Fah Yeow International Limited’s quoted price sits in the lower half of its reported 52-week range, 13.92% below the high.
HK$5.49-HK$0.01 (-0.09%)
Charmacy Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.81% below the high.
HK$0.63-HK$0.01 (-1.56%)
Zhongzhi Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
HK$0.71+HK$0.03 (+3.65%)
Vincent Medical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 34.86% below the high.
HK$0.38+HK$0.04 (+10.29%)
Wai Yuen Tong Medicine Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 23.47% below the high.
HK$1.39+HK$0.01 (+0.72%)
Suzhou Basecare Medical Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 47.55% below the high.
HK$0.62-HK$0.03 (-3.88%)
Yunkang Group Limited’s quoted price sits in the lower half of its reported 52-week range, 50.4% below the high.
